Vera Lúcia Dantas Nunes Caldeira de Moura
AuthID: R-000-M8N
11
TITLE: Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and trends
AUTHORS: Fonseca, NA; Lopes, RM; Cruz, AF; C. Gregório, A; Valério Fernandes, Â; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: Handbook of Nanomaterials for Cancer Theranostics
AUTHORS: Fonseca, NA; Lopes, RM; Cruz, AF; C. Gregório, A; Valério Fernandes, Â; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2018, SOURCE: Handbook of Nanomaterials for Cancer Theranostics
12
TITLE: The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors
AUTHORS: Fonseca, NA; Cruz, AF; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 113
AUTHORS: Fonseca, NA; Cruz, AF; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: Critical Reviews in Oncology/Hematology, VOLUME: 113
13
TITLE: Targeting Cancer Stem Cells and Non-Stem Cancer Cells: The Potential of Lipid-Based Nanoparticles
AUTHORS: Cruz, AF; Fonseca, NA; Moura, V; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 23, ISSUE: 43
AUTHORS: Cruz, AF; Fonseca, NA; Moura, V; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CURRENT PHARMACEUTICAL DESIGN, VOLUME: 23, ISSUE: 43
14
TITLE: Synergistic cytotoxicity of targeted liposomes containing doxorubicin and C6-ceramide against nucleolin-overexpressing ovarian cancer cells is supported by the downregulation of the Akt pathway
AUTHORS: Cruz, AF; Fonseca, NA; Sampaio, SF; Moura, V; Almeida, RD ; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CANCER RESEARCH, VOLUME: 77, ISSUE: 13_Supplement
AUTHORS: Cruz, AF; Fonseca, NA; Sampaio, SF; Moura, V; Almeida, RD ; Simoes, S; Moreira, JN;
PUBLISHED: 2017, SOURCE: CANCER RESEARCH, VOLUME: 77, ISSUE: 13_Supplement
INDEXED IN: 
WOS 
CrossRef
WOS CrossRef15
TITLE: Inoculated cell density as a determinant factor of the growth dynamics and metastatic efficiency of a breast cancer murine model
AUTHORS: Gregório, AC; Fonseca, NA; Moura, V; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2016, SOURCE: PLoS ONE, VOLUME: 11, ISSUE: 11
AUTHORS: Gregório, AC; Fonseca, NA; Moura, V; Lacerda, M; Figueiredo, P; Simões, S; Dias, S; Moreira, JN;
PUBLISHED: 2016, SOURCE: PLoS ONE, VOLUME: 11, ISSUE: 11
16
TITLE: Advances on nucleic acid delivery with nonviral vectors
AUTHORS: Lopes, RM; Fonseca, NA; Cruz, AF; Gregório, AC; Valério Fernandes, Â; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2016, SOURCE: Bioinspired Materials for Medical Applications
AUTHORS: Lopes, RM; Fonseca, NA; Cruz, AF; Gregório, AC; Valério Fernandes, Â; Moura, V; Simões, S; Moreira, JN;
PUBLISHED: 2016, SOURCE: Bioinspired Materials for Medical Applications
17
TITLE: Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination Full Text
AUTHORS: Nuno A Fonseca; Rodrigues, Ana Sofia Rodrigues; Ana S. Rodrigues; A. S. Rodrigues ; Paulo Rodrigues-Santos ; Vera Alves; Ana C Gregorio; Angela Valerio Fernandes; Ligia C Gomes da Silva; Manuel Santos Rosa; Vera Moura; Joao Ramalho Santos ; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2015, SOURCE: BIOMATERIALS, VOLUME: 69
AUTHORS: Nuno A Fonseca; Rodrigues, Ana Sofia Rodrigues; Ana S. Rodrigues; A. S. Rodrigues ; Paulo Rodrigues-Santos ; Vera Alves; Ana C Gregorio; Angela Valerio Fernandes; Ligia C Gomes da Silva; Manuel Santos Rosa; Vera Moura; Joao Ramalho Santos ; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2015, SOURCE: BIOMATERIALS, VOLUME: 69
18
TITLE: Simultaneous active intracellular delivery of doxorubicin and C6-ceramide shifts the additive/antagonistic drug interaction of non-encapsulated combination Full Text
AUTHORS: Nuno A Fonseca; Ligia C Gomes da Silva; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2014, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 196
AUTHORS: Nuno A Fonseca; Ligia C Gomes da Silva; Vera Moura; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2014, SOURCE: JOURNAL OF CONTROLLED RELEASE, VOLUME: 196
19
TITLE: Targeting nucleolin in lung cancer - an emerging strategy to overcome stroma-mediated anti-VEGF resistance Full Text
AUTHORS: Valerio Fernandes, A; Fonseca, N; Moura, V; Ladeirinha, A; Ferreira, T; Alarcao, A; Carvalho, L; Simoes, S; Moreira, JN;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 50
AUTHORS: Valerio Fernandes, A; Fonseca, N; Moura, V; Ladeirinha, A; Ferreira, T; Alarcao, A; Carvalho, L; Simoes, S; Moreira, JN;
PUBLISHED: 2014, SOURCE: EUROPEAN JOURNAL OF CANCER, VOLUME: 50
INDEXED IN: WOS
WOS20
TITLE: Targeting nucleolin: A potential strategy to overcome stroma-mediated bevacizumab resistance in lung cancer
AUTHORS: Angela Valerio Fernandes; Nuno Fonseca; Vera Moura; Ana Ladeirinha; Teresa Ferreira; Ana Alarcao; Lina Carvalho; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2014, SOURCE: 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 74, ISSUE: 19
AUTHORS: Angela Valerio Fernandes; Nuno Fonseca; Vera Moura; Ana Ladeirinha; Teresa Ferreira; Ana Alarcao; Lina Carvalho; Sergio Simoes; Joao Nuno Moreira;
PUBLISHED: 2014, SOURCE: 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR) in CANCER RESEARCH, VOLUME: 74, ISSUE: 19
INDEXED IN: WOS
WOS